UBS Group’s Evogene EVGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.61K | Sell |
|
|||||
|
2025
Q1 | $23.4K | Sell |
|
|||||
|
2024
Q4 | $41.2K | Buy |
|
|||||
|
2024
Q3 | $26.4K | Buy |
|
|||||
|
2024
Q2 | $42.9K | Buy |
|
|||||
|
2024
Q1 | $46.9K | Buy |
|
|||||
|
2023
Q4 | $47K | Buy |
|
|||||
|
2023
Q3 | $21.1K | Buy |
|
|||||
|
2023
Q2 | $31.1K | Buy |
|
|||||
|
2023
Q1 | $13.2K | Sell |
|
|||||
|
2022
Q4 | $14.7K | Buy |
|
|||||
|
2022
Q3 | $15K | Buy |
|
|||||
|
2022
Q2 | $11K | Sell |
|
|||||
|
2022
Q1 | $47K | Sell |
|
|||||
|
2021
Q4 | $90K | Buy |
|
|||||
|
2021
Q3 | $38K | Sell |
|
|||||
|
2021
Q2 | $121K | Buy |
|
|||||
|
2021
Q1 | $139K | Buy |
|
|||||
|
2020
Q4 | $129K | Sell |
|
|||||
|
2020
Q3 | $514K | Sell |
|
|||||
|
2020
Q2 | $316K | Sell |
|
|||||
|
2020
Q1 | $1.6M | Sell |
|
|||||
|
2019
Q4 | $2.08M | Sell |
|
|||||
|
2019
Q3 | $2.23M | Sell |
|
|||||
|
2019
Q2 | $2.33M | Buy |
|
|||||
|
2019
Q1 | $2.58M | Buy |
|
|||||
|
2018
Q4 | $2.61M | Buy |
|
|||||
|
2018
Q3 | $4.06M | Buy |
|
|||||
|
2018
Q2 | $3.68M | Buy |
|
|||||
|
2018
Q1 | $4.05M | Sell |
|
|||||
|
2017
Q4 | $3.92M | Buy |
|
|||||
|
2017
Q3 | $5.45M | Buy |
|
|||||
|
2017
Q2 | $5.82M | Buy |
|
|||||
|
2017
Q1 | $5.63M | Buy |
|
|||||
|
2016
Q4 | $4.88M | Buy |
|
|||||
|
2016
Q3 | $5.25M | Buy |
|
|||||
|
2016
Q2 | $4.66M | Buy |
|
|||||
|
2016
Q1 | $4.49M | Buy |
|
|||||
|
2015
Q4 | $5.18M | Buy |
|
|||||
|
2015
Q3 | $2.45M | Buy |
|
|||||
|
2015
Q2 | $2.06M | Buy |
|
|||||
|
2015
Q1 | $1.97M | Buy |
|
|||||
|
2014
Q4 | $1.37M | Buy |
|